New paradigm for radiation in multiple myeloma: lower yet effective dose to avoid radiation toxicity

Haematologica. 2020 Jul;105(7):e355-e357. doi: 10.3324/haematol.2019.235804. Epub 2020 Jan 9.

Authors

Adnan Elhammali¹, Behrang Amini², Ethan B Ludmir¹, Jillian R Gunther¹, Sarah A Milgrom³, Chelsea C Pinnix¹, Therese Andraos¹, Alison Yoder¹, Donna Weber⁴, Robert Orlowski⁴, Elisabet Manasanch⁴, Krina Patel⁴, Paolo Strati⁴, Ranjit Nair⁴, Hans C Lee⁴, Sheeba Thomas⁴, Swaminathan Iyer⁴, Gregory Kaufmann⁴, Naveen Garg², Bouthaina S Dabaja¹

Affiliations

¹ Department of Radiation Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX.
² Department of Diagnostic Radiology, The University of Texas MD Anderson Cancer Center, Houston, TX.
³ Department of Radiation Oncology, University of Colorado School of Medicine, Aurora, CO.
⁴ Department of Lymphoma/Myeloma, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.

No abstract available

Publication types

Letter
Research Support, N.I.H., Extramural

MeSH terms

Humans
Multiple Myeloma*
Radiation Injuries* / epidemiology
Radiation Injuries* / etiology
Radiation Injuries* / prevention & control

Grants and funding

P30 CA016672/CA/NCI NIH HHS/United States